The prescription drugs that pharmaceutical companies spend the most money promoting have the least therapeutic value. Studies show the top 3 most heavily-promoted drugs in the US (1 blood thinner and 2 diabetes drugs) are rated as the least likely to be “effective, safe, affordable, novel, or represent a genuine advance in treating a disease.” Source Source 2